GlycoMimetics (NASDAQ:GLYC) Earns Sell Rating from Analysts at StockNews.com
Equities researchers at StockNews.com began coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a research report issued on Friday. The brokerage set a “sell” rating on the biotechnology company’s stock. GlycoMimetics Price Performance Shares of NASDAQ GLYC opened at $0.26 on Friday. GlycoMimetics has a fifty-two week low of $0.14 and a […]
Equities researchers at StockNews.com began coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a research report issued on Friday. The brokerage set a “sell” rating on the biotechnology company’s stock. GlycoMimetics Price Performance Shares of NASDAQ GLYC opened at $0.26 on Friday. GlycoMimetics has a fifty-two week low of $0.14 and a […]
